简体中文
English
Leading Experts in DMPK & Early Toxicology Experts for Novel Drug Development
Services
About Strivita Pharma
Suzhou Strivita Pharma Technology Co., Ltd. operates as a specialized preclinical Contract Research Organization (CRO). We deliver integrated one-stop solutions encompassing DMPK (Drug Metabolism and Pharmacokinetics) profiling and non-clinical toxicology assessment, catering to pharmaceutical manufacturers, academic institutions and research laboratories worldwide.
Aligning with the full lifecycle development demands of novel therapeutics, we have established a comprehensive and interconnected technical service portfolio, spanning in vitro DMPK druggability evaluation, in vivo pharmacokinetic investigations, bioanalytical method establishment & sample quantification, as well as early-stage toxicological safety profiling. Backed by a cohort of seasoned technical experts, fully standardized laboratory infrastructure and an extensive track record of successfully delivered R&D programs, we furnish robust, regulation-compliant and time-efficient technical backing to translate fundamental pharmaceutical research into viable clinical trial submissions. Our integrated service framework enables partners to streamline their drug development timelines and mitigate R&D risks throughout the preclinical pipeline.
Suzhou Strivita Pharma Technology Co., Ltd. operates as a specialized preclinical Contract Research Organization (CRO). We deliver integrated one-stop solutions encompassing DMPK (Drug Metabolism and Pharmacokinetics) profiling and non-clinical toxicology assessment, catering to pharmaceutical manufacturers, academic institutions and research laboratories worldwide.
Aligning with the full lifecycle development demands of novel therapeutics, we have established a comprehensive and interconnected technical service portfolio, spanning in vitro DMPK druggability evaluation, in vivo pharmacokinetic investigations, bioanalytical method establishment & sample quantification, as well as early-stage toxicological safety profiling. Backed by a cohort of seasoned technical experts, fully standardized laboratory infrastructure and an extensive track record of successfully delivered R&D programs, we furnish robust, regulation-compliant and time-efficient technical backing to translate fundamental pharmaceutical research into viable clinical trial submissions. Our integrated service framework enables partners to streamline their drug development timelines and mitigate R&D risks throughout the preclinical pipeline.
About Strivita Pharma
News Center
Contact Us
Thank you for your attention to us. Please feel free to contact us anytime!
Telephone
zhanyuan@strivita-biotech.com
Address
+86 13291166611
1/F, Bldg 15, CECEP (Suzhou) Env Tech Park, 18 Dongchang Rd, Suzhou Industrial Park, Jiangsu, China
Company WeChat
Mobile web page
© 2025 Suzhou Strivita Pharma Technology Co., Ltd. All rights reserved. www.strivita-biotech.com